These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22554357)

  • 1. Use of immune function test in monitoring immunosuppression in liver transplant recipients.
    Te HS; Dasgupta KA; Cao D; Satoskar R; Mohanty SR; Reau N; Millis JM; Jensen DM
    Clin Transplant; 2012; 26(6):826-32. PubMed ID: 22554357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N; Hanouneh IA; Lopez R; Zein NN
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipients.
    Vittoraki AG; Boletis JN; Darema MN; Kostakis AJ; Iniotaki AG
    Transplant Proc; 2014; 46(1):108-14. PubMed ID: 24507034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
    Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
    Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
    J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of CD4 T-cell adenosine triphosphate levels monitoring in elderly renal transplant recipients.
    Wu Z; Zhou H; Yang S; Cai J; Wang Q; Liao L; Tan J
    Transplant Proc; 2012 Dec; 44(10):2986-91. PubMed ID: 23195011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring.
    Zhou T; Xue F; Han LZ; Xi ZF; Li QG; Xu N; Zhang JJ; Xia Q
    J Dig Dis; 2011 Dec; 12(6):467-75. PubMed ID: 22118697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC; Goss JA; Rooney CM; Heslop HE; Barshes NR; Caldwell YM; Gee AP; Scott JD; Savoldo B
    Clin Transplant; 2006; 20(6):689-94. PubMed ID: 17100717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
    Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cell function assay in pediatric heart transplant recipients.
    Wong MS; Boucek R; Kemna M; Rutledge J; Law Y
    Pediatr Transplant; 2014 Aug; 18(5):485-90. PubMed ID: 24930882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.